768 Participants Needed

Telehealth Pulmonary Rehabilitation for COPD

Recruiting in Cincinnati (<99 mi)
+13 other locations
SP
MJ
EP
Overseen ByElizabeth Plan
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 2 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to compare the efficacy and safety of a real time video telehealth pulmonary rehabilitation intervention with standard of care in patients hospitalized for an exacerbation of chronic obstructive pulmonary disease (COPD) to determine the impact on hospital readmissions and respiratory morbidity, and to investigate the cost-effectiveness of the intervention.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your doctor.

Is telehealth pulmonary rehabilitation safe for people with COPD?

Research shows that telehealth pulmonary rehabilitation is safe for people with COPD, with no major adverse events reported in studies.12345

How is the treatment 'Video Telehealth Pulmonary Rehabilitation' different from other treatments for COPD?

Video Telehealth Pulmonary Rehabilitation is unique because it allows COPD patients to participate in rehabilitation programs from home using video technology, making it more accessible and convenient compared to traditional in-person rehabilitation sessions. This approach can enhance patient participation and provide clinical and social benefits, especially for those who have limited access to conventional rehabilitation centers.34678

What data supports the effectiveness of the treatment Video Telehealth Pulmonary Rehabilitation, Telehealth Pulmonary Rehabilitation, Virtual Pulmonary Rehabilitation, Telerehabilitation for COPD?

Research shows that telehealth pulmonary rehabilitation for COPD patients is feasible and can provide positive clinical and social benefits, making it a promising alternative to traditional in-person programs, especially when access to such programs is limited.34678

Who Is on the Research Team?

SP

Surya Bhatt, MD

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

This trial is for adults aged 40-85 hospitalized with a flare-up of COPD, willing to follow the study plan and give consent. Excluded are those with terminal illnesses, severe heart failure, cognitive issues preventing safe participation, non-English speakers, certain immunosuppressed states or active cancers, recent heart attacks or on invasive ventilation.

Inclusion Criteria

I am in the hospital for a severe COPD flare-up.
I have been diagnosed with COPD.
I am between 40 and 85 years old.
See 2 more

Exclusion Criteria

I have a terminal illness and/or am receiving hospice care.
I have severe heart failure with significant symptoms or very poor heart pump function.
I am currently receiving chemotherapy or radiation for my cancer.
See 15 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks
1 visit (in-person)

Treatment

Participants receive video telehealth pulmonary rehabilitation sessions three times a week for 12 weeks

12 weeks
36 sessions (virtual)

Follow-up

Participants are monitored for safety and effectiveness after treatment, with assessments at 13 weeks and 52 weeks

39 weeks
Monthly phone calls, assessments at 13 and 52 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Video Telehealth Pulmonary Rehabilitation
Trial Overview The study tests if video telehealth pulmonary rehabilitation can reduce hospital readmissions in COPD patients compared to standard care. It will assess effectiveness and safety of this method and its cost-effectiveness.
How Is the Trial Designed?
2Treatment groups
Active Control
Group I: Standard of CareActive Control1 Intervention
Group II: Video Telehealth Pulmonary RehabilitationActive Control1 Intervention

Video Telehealth Pulmonary Rehabilitation is already approved in United States, European Union for the following indications:

๐Ÿ‡บ๐Ÿ‡ธ
Approved in United States as Video Telehealth Pulmonary Rehabilitation for:
๐Ÿ‡ช๐Ÿ‡บ
Approved in European Union as Telerehabilitation for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

National Heart, Lung, and Blood Institute (NHLBI)

Collaborator

Trials
3,987
Recruited
47,860,000+

Published Research Related to This Trial

Tele-pulmonary rehabilitation has emerged as a feasible and effective alternative to traditional in-person pulmonary rehabilitation for patients with chronic obstructive pulmonary disease (COPD), especially during the COVID-19 pandemic.
A hybrid model combining both in-person and remote components may be the best approach for delivering pulmonary rehabilitation in the future, but further high-quality studies and collaboration are needed to optimize this model.
Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions.Wen, J., Milne, S., Sin, DD.[2023]
Telerehabilitation for COPD patients is a safe and effective alternative to conventional pulmonary rehabilitation, showing no inferior results in improving functional exercise capacity and quality of life across ten studies involving 1492 participants.
Despite the positive outcomes, the study highlights a significant variability in telerehabilitation methods, indicating a need for a standardized approach to therapy and technology use in future implementations.
Effects of Home-Based Training with Internet Telehealth Guidance in COPD Patients Entering Pulmonary Rehabilitation: A Systematic Review.Hartman, M., Minรกrikovรก, J., Batalik, L., et al.[2023]
Telehealthcare significantly improves physical activity levels in patients with chronic obstructive pulmonary disease (COPD), with an average increase of 64.7 minutes compared to standard care, based on a systematic review of 9 studies involving 982 patients.
However, telehealthcare did not show significant differences in physical capacity or dyspnea levels, indicating that while it can enhance activity, it may not directly improve other aspects of COPD management.
Telehealthcare in COPD: a systematic review and meta-analysis on physical outcomes and dyspnea.Lundell, S., Holmner, ร…., Rehn, B., et al.[2022]

Citations

Pulmonary rehabilitation in a postcoronavirus disease 2019 world: feasibility, challenges, and solutions. [2023]
Effects of Home-Based Training with Internet Telehealth Guidance in COPD Patients Entering Pulmonary Rehabilitation: A Systematic Review. [2023]
Telehealthcare in COPD: a systematic review and meta-analysis on physical outcomes and dyspnea. [2022]
Delivering Pulmonary Rehabilitation for Patients with Chronic Obstructive Pulmonary Disease at Home Using Telehealth: A Review of the Literature. [2020]
Telerehabilitation Programme as a Maintenance Strategy for COPD Patients: A 12-Month Randomized Clinical Trial. [2021]
The Accessibility, Feasibility, and Safety of a Standardized Community-based Tele-Pulmonary Rehab Program for Chronic Obstructive Pulmonary Disease: A 3-Year Real-World Prospective Study. [2022]
Feasibility of an online platform delivery of pulmonary rehabilitation for individuals with chronic respiratory disease. [2021]
Efficacy of respiratory tele-rehabilitation in COPD patients: Systematic review and meta-analysis. [2022]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity